MONTE ROSA Trademark

Trademark Overview

On Thursday, February 4, 2021, a trademark application was filed for MONTE ROSA with the United States Patent and Trademark Office. The USPTO has given the MONTE ROSA trademark a serial number of 90510273. The federal status of this trademark filing is STATEMENT OF USE - TO EXAMINER as of Tuesday, November 12, 2024. This trademark is owned by Monte Rosa Therapeutics, Inc.. The MONTE ROSA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and therapeutic preparations for the treatment of cancer, immunological diseases, inflammatory diseases, neurological diseases, and genetic disorders; pharmaceutical and therapeutic preparations for modulating protein degradation pathways
monte rosa

General Information

Serial Number90510273
Word MarkMONTE ROSA
Filing DateThursday, February 4, 2021
Status748 - STATEMENT OF USE - TO EXAMINER
Status DateTuesday, November 12, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 19, 2021

Trademark Statements

Goods and ServicesPharmaceutical and therapeutic preparations for the treatment of cancer, immunological diseases, inflammatory diseases, neurological diseases, and genetic disorders; pharmaceutical and therapeutic preparations for modulating protein degradation pathways
Translation of Words in MarkThe English translation of the wording "MONTE ROSA" in the mark is "pink mountain".

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, May 8, 2021
Primary Code005
First Use Anywhere DateWednesday, August 31, 2022
First Use In Commerce DateWednesday, August 31, 2022

Trademark Owner History

Party NameMonte Rosa Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02118
Party NameMonte Rosa Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02135

Trademark Events

Event DateEvent Description
Monday, February 8, 2021NEW APPLICATION ENTERED
Saturday, May 8, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, August 27, 2021ASSIGNED TO EXAMINER
Tuesday, August 31, 2021NON-FINAL ACTION WRITTEN
Tuesday, August 31, 2021NON-FINAL ACTION E-MAILED
Tuesday, August 31, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, September 13, 2021EXAMINERS AMENDMENT -WRITTEN
Monday, September 13, 2021EXAMINERS AMENDMENT E-MAILED
Monday, September 13, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, September 13, 2021EXAMINER'S AMENDMENT ENTERED
Monday, September 13, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 29, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 19, 2021PUBLISHED FOR OPPOSITION
Tuesday, April 26, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, October 19, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 14, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 26, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 26, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, June 3, 2022SOU TEAS EXTENSION RECEIVED
Friday, June 3, 2022SOU EXTENSION 1 FILED
Friday, June 3, 2022SOU EXTENSION 1 GRANTED
Tuesday, June 7, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 6, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, December 6, 2022TEAS REQUEST TO DIVIDE RECEIVED
Tuesday, December 6, 2022SOU EXTENSION 2 FILED
Tuesday, December 6, 2022DIVISIONAL REQUEST RECEIVED
Wednesday, January 4, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, January 18, 2023SOU EXTENSION 2 GRANTED
Wednesday, January 18, 2023DIVISIONAL PROCESSING COMPLETE
Thursday, January 19, 2023CORRECTED NOA E-MAILED
Thursday, January 19, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 24, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, May 24, 2023SOU EXTENSION 3 FILED
Wednesday, May 24, 2023SOU EXTENSION 3 GRANTED
Friday, May 26, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 20, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, July 20, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, July 20, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 28, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, November 28, 2023SOU EXTENSION 4 FILED
Wednesday, November 29, 2023SOU EXTENSION 4 GRANTED
Thursday, November 30, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 22, 2024SOU TEAS EXTENSION RECEIVED
Monday, April 22, 2024SOU EXTENSION 5 FILED
Monday, April 22, 2024SOU EXTENSION 5 GRANTED
Tuesday, April 23, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 12, 2024USE AMENDMENT FILED
Tuesday, November 12, 2024STATEMENT OF USE PROCESSING COMPLETE
Tuesday, November 12, 2024TEAS STATEMENT OF USE RECEIVED

Related Keywords

rosa monte diseases pharmaceutical preparations therapeutic modulating degradation pathways disorders protein inflammatory